Targeting ATR in patients with cancer von Ngoi, Natalie Y. L., Pilié, Patrick G., McGrail, Daniel J., Zimmermann, Michal, Schlacher, Katharina, Yap, Timothy A.

Volltext

Uterine serous carcinoma von Bogani, Giorgio, Ray-Coquard, Isabelle, Concin, Nicole, Ngoi, Natalie Y.L., Morice, Philippe, Enomoto, Takayuki, Takehara, Kazuhiro, Denys, Hannelore, Nout, Remi A., Lorusso, Domenica, Vaughan, Michelle M., Bini, Marta, Takano, Masashi, Provencher, Diane, Indini, Alice, Sagae, Satoru, Wimberger, Pauline, Póka, Robert, Segev, Yakir, Kim, Se Ik, Candido dos Reis, Francisco J., Lopez, Salvatore, Mariani, Andrea, Leitao, Mario M., Raspagliesi, Francesco, Panici, Pieluigi Benedetti, Di Donato, Violante, Muzii, Ludovico, Colombo, Nicoletta, Scambia, Giovanni, Pignata, Sandro, Monk, Bradley J.

Volltext

Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases von Chia, Daryl K. A., Sundar, Raghav, Kim, Guowei, Ang, Jia Jun, Lum, Jeffrey H. Y., Nga, Min En, Goh, Giap Hean, Seet, Ju Ee, Chee, Cheng Ean, Tan, Hon Lyn, Ho, Jingshan, Ngoi, Natalie Y. L., Lee, Matilda X. W., Muthu, Vaishnavi, Chan, Gloria H. J., Pang, Angela S. L., Ang, Yvonne L. E., Choo, Joan R. E., Lim, Joline S. J., Teh, Jun Liang, Lwin, Aung, Soon, Yuen, Shabbir, Asim, So, Jimmy B. Y., Yong, Wei Peng

Volltext

Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase... von Kim, Yoo-Na, Park, Boram, Kim, Jae Weon, Kim, Byoung Gie, Kim, Sang Wun, Kim, Hee Seung, Choi, Chel Hun, Lim, Myong Cheol, YL Ngoi, Natalie, SP Tan, David, Lee, Jung-Yun

Volltext

The redox-senescence axis and its therapeutic targeting von Ngoi, Natalie YL, Liew, Angeline QX, Chong, Stephen J.F., Davids, Matthew S., Clement, Marie-Veronique, Pervaiz, Shazib

Volltext

A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma von Heong, Valerie, Tan, Tuan Z, Miwa, Maiko, Ye, Jieru, Lim, Diana, Herrington, C Simon, Iida, Yasushi, Yano, Mitsutake, Yasuda, Masanori, Ngoi, Natalie YL, Wong, SB Justin, Okamoto, Aikou, Gourley, Charlie, Hasegawa, Kosei, Tan, David SP, Huang, Ruby YJ

Volltext

PRL-3 dephosphorylates p38 MAPK to promote cell survival under stress von Shi, Yin, Xu, Shengfeng, Ngoi, Natalie Y.L., Zeng, Qi, Ye, Zu

Volltext

Rag GTPases suppress PRL-3 degradation and predict poor clinical diagnosis of cancer patients with low PRL-3 mRNA expression von Shi, Yin, Xu, Shengfeng, Ngoi, Natalie Y.L., Hui, Yuanjian, Ye, Zu

Volltext

A Tale of Two Checkpoints: ATR Inhibition and PD-(L)1 Blockade von Ngoi, Natalie Y.L, Peng, Guang, Yap, Timothy A

Volltext

Targeting Cell Metabolism as Cancer Therapy von Ngoi, Natalie Y. L., Eu, Jie Qing, Hirpara, Jayshree, Wang, Lingzhi, Lim, Joline S. J., Lee, Soo-Chin, Lim, Yaw-Chyn, Pervaiz, Shazib, Goh, Boon Cher, Wong, Andrea L. A.

Volltext

Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers von Ngoi, Natalie Y L, Tang, Tin-Yun, Gaspar, Catia F, Pavlick, Dean C, Buchold, Gregory M, Scholefield, Emma L, Parimi, Vamsi, Huang, Richard S P, Janovitz, Tyler, Danziger, Natalie, Levy, Mia A, Pant, Shubham, De Armas, Anaemy Danner, Kumpula, David, Ross, Jeffrey S, Javle, Milind, Rodon Ahnert, Jordi

Volltext

Targeting the replication stress response through synthetic lethal strategies in cancer medicine von Ngoi, Natalie Y. L., Pham, Melissa M., Tan, David S. P., Yap, Timothy A.

Volltext

PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report von Sachdeva, Manavi, Ngoi, Natalie Y L, Lim, Diana, Poon, Michelle L M, Thian, Yee Liang, Lim, Yi Wan, Lim, Siew Eng, Tong, Pearl, Lum, Jeffrey H Y, Ng, Joseph, Ilancheran, Arunachalam, Domingo, Efren J, Low, Jeffrey J H, Tan, David S P

Volltext

Clear cell carcinoma of the endometrium von Bogani, Giorgio, Ray-Coquard, Isabelle, Concin, Nicole, Ngoi, Natalie Y.L., Morice, Philippe, Enomoto, Takayuki, Takehara, Kazuhiro, Denys, Hannelore, Lorusso, Domenica, Coleman, Robert, Vaughan, Michelle M., Takano, Masashi, Provencher, Diane, Sagae, Satoru, Wimberger, Pauline, Póka, Robert, Segev, Yakir, Kim, Se Ik, Kim, Jae-Weon, Candido dos Reis, Francisco J., Mariani, Andrea, Leitao, Mario M., Makker, Viky, Rustum, Nadeem Abu, Vergote, Ignace, Zannoni, Gian Franco, Tan, David S.P., McCormack, Mary, Bini, Marta, Lopez, Salvatore, Raspagliesi, Francesco, Panici, Pierluigi Benedetti, di Donato, Violante, Muzii, Ludovico, Colombo, Nicoletta, Scambia, Giovanni, Pignata, Sandro, Monk, Bradley J.

Volltext

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer von Lim, Joline S J, Wong, Andrea L A, Ow, Samuel G W, Ngoi, Natalie Y L, Chan, Gloria H J, Ang, Yvonne L E, Chong, Wan Qin, Lim, Siew Eng, Lim, Yi Wan, Lee, Matilda, Choo, Joan R E, Tan, Hon Lyn, Yong, Wei Peng, Soo, Ross A, Tan, David S P, Chee, Cheng Ean, Sundar, Raghav, Yadav, Kritika, Jain, Supriya, Wang, Lingzhi, Tai, Bee Choo, Goh, Boon Cher, Lee, Soo-Chin

Volltext

Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer von Tan, David SP, Ngoi, Natalie YL, Syn, Nicholas LX, Goh, Robby M, Goh, Boon Cher, Huang, Ruby Yun-Ju, Soon, Yu Yang, James, Elizabeth, Cook, Adrian, Clamp, Andrew, Tan, David SP

Volltext

ASO Visual Abstract: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases von Chia, Daryl K. A., Sundar, Raghav, Kim, Guowei, Ang, Jia Jun, Lum, Jeffrey H. Y., Nga, Min En, Goh, Giap Hean, Seet, Je Ee, Chee, Cheng Ean, Tan, Hon Lyn, Ho, Jingshan, Ngoi, Natalie Y. L., Lee, Matilda X. W., Muthu, Vaishnavi, Chan, Gloria H. J., Pang, Angela S. L., Ang, Yvonne L. E., Choo, Joan R. E., Lim, Joline S. J., Teh, Jun Liang, Lwin, Aung, Soon, Yuen, Shabbir, Asim, So, Jimmy B. Y., Yong, Wei Peng

Volltext

Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises von Pham, Melissa M., Ngoi, Natalie Y. L., Peng, Guang, Tan, David S. P., Yap, Timothy A.

Volltext

Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre von Chan, Gloria HJ, Gwee, Yong Xiang, Low, Jia Li, Huang, Yiqing, Chan, Zhi Yao, Choo, Joan RE, Ngoi, Natalie YL, LE Ang, Yvonne, Muthu, Vaishnavi, Chong, Wan Qin, Wong, Alvin, Soo, Ross A.

Volltext

The role of molecular tests for adjuvant and post-surgical treatment in gynaecological cancers von Wijaya, Silvana Talisa, Ngoi, Natalie YL, Tan, David SP

Volltext